Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?

OBJECTIVES/HYPOTHESIS: To examine whether there is a rationale for iron treatments precipitating nosebleeds (epistaxis) in a subgroup of patients with hereditary hemorrhagic telangiectasia (HHT). STUDY DESIGN: Survey evaluation of HHT patients, and a randomized control trial in healthy volunteers. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Shovlin, Claire L., Gilson, Clare, Busbridge, Mark, Patel, Dilip, Shi, Chenyang, Dina, Roberto, Abdulla, F. Naziya, Awan, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Head and Neck
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095791/
https://www.ncbi.nlm.nih.gov/pubmed/27107394
http://dx.doi.org/10.1002/lary.25959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095791/
https://www.ncbi.nlm.nih.gov/pubmed/27107394
http://dx.doi.org/10.1002/lary.25959

Ejemplares similares